On Oct. 7, 2020, in a continuing effort to provide the facts about ID NOW to support public health interests, Abbott shared new interim clinical data results on its ID NOW COVID-19 rapid test. The results confirmed the data submitted to the FDA in March for Emergency Use Authorization and the interim results that Abbott shared in its May 21 press release.